Analysts Cut Bath & Body Works' Price Target Post Outlook Revision

Telsey Advisory Group analyst Dana Telsey reiterated Outperform rating on Bath & Body Works Inc BBWI and lowered the price target to $40 from $60 (23% upside)
The analyst said the company’s move in lowering Q2 guidance reflected a challenging macro environment and unprecedented inflation levels weighing on consumer sentiment and demand.
Dana believes traffic trends have sequentially declined from Q1, and the management feels lower-income consumers are heavily impacted by inflation and have become more price sensitive.
While the moderated outlook is somewhat disappointing, the analyst believes modest stock reaction is evidence that the market had already contemplated the potential softness.
Dana noted that the company is poised for incremental growth with a solid pipeline of new launches planned in FY22 and increased investments in infrastructure and systems.
Also Read: Why Bath & Body Works Stock Is Falling
Baird analyst Mark Altschwager maintained Outperform rating on the company and lowered the price target to $40 from $50.
B. Riley Securities analyst Susan Anderson reiterated a Buy rating and reduced the price target from $67 to $44 (35% upside).
Morgan Stanley analyst Kimberley Greemberger maintained an Overweight rating and raised the price target to $66 (102% upside) from $64.
BMO Capital analyst Simeon Siegel maintained an Outperform rating on the shares and lowered the price target to $45 from $65 (38% upside).
Raymond James analyst Olivia Tong maintained a Strong Buy rating on the shares and lowered the price target to $43 from $45 (32% upside).
Citigroup analyst Paul Lejuez maintained a Buy and reduced the price target from $54 to $42 (29% upside).
Price Action: BBWI shares are trading higher by 4.87% at $32.61 on the last check Thursday.

Market News and Data brought to you by Benzinga APIs

Comments

Analyst Calendar

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga